Skip to content

Lightfusion LED System

by Vitage Led, Ltd.

510(k) K162556

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK162556 Date24 Mar 2017ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
GEX
Device Class
Class II
Regulation
21 CFR Part 878.4810
Advisory Committee
General, Plastic Surgery
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Lightfusion LED System is a powered laser surgical instrument classified under Powered Laser Surgical Instrument (Product Code GEX) and designed for photobiomodulation. It emits non-thermal red (630 nm) and near-infrared (830 nm) light via LED face pads, targeting periorbital wrinkles through controlled energy delivery in the red and near-infrared spectrum regions. This device operates as a portable, table-top unit, leveraging LED technology to provide localized treatment without thermal effects.

The Lightfusion LED System is supplied as a reusable medical device and is intended for use in clinical settings by trained professionals. It is not sterile at shipment and requires appropriate cleaning and maintenance per manufacturer guidelines. The device holds FDA 510(k) clearance (K162556) under the Substantially Equivalent (SESE) determination, classified for general and plastic surgery applications. Compliance with regulatory standards ensures safe integration into surgical or aesthetic treatment workflows.

Questions

AI-generated answers, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What specific types of skin concerns does the Lightfusion LED System target, and how does it work?

    The Lightfusion LED System targets periorbital wrinkles by delivering photobiomodulation through non-thermal red (630 nm) and near-infrared (830 nm) LED light. Unlike thermal treatments, it avoids heat-related damage while promoting localized tissue response to reduce fine lines around the eyes.

  • Is the Lightfusion LED System intended for use in surgical or aesthetic procedures, and who should operate it?

    The device is classified under Powered Laser Surgical Instruments (Product Code GEX) and is designed for use in clinical settings by trained professionals, though it’s not explicitly limited to surgical contexts. Its FDA clearance under General/Plastic Surgery (SU Advisory Committee) suggests suitability for aesthetic treatments like wrinkle reduction, but operation requires proper training.

  • How is the Lightfusion LED System supplied, and what cleaning or maintenance is required?

    The Lightfusion LED System is a reusable medical device shipped non-sterile, so it must be cleaned and maintained according to the manufacturer’s guidelines before each use. Unlike single-use devices, it’s built for repeated clinical applications but requires proper sterilization procedures between patients.

  • What regulatory pathway did the Lightfusion LED System follow to gain FDA clearance, and what does that mean for its use?

    The device received FDA 510(k) clearance (K162556) under a Substantially Equivalent (SESE) determination, meaning it was deemed comparable to a legally marketed predicate device. This clearance allows its use in clinical settings for photobiomodulation, but clinicians should confirm compliance with current FDA guidelines and manufacturer instructions for safe integration into their workflow.